We noted that amongst B-ALL patients, the TCF3/PBX1 subtype (Pre-B) (56) demonstrated a much more prominent increase in mortality when ARID5B expression was below the median (Figure 5E). The gene discussed is ARID5B; the disease is acute lymphoblastic leukemia.